OraSure Technologies Inc (OSUR)

Industry Medical Instruments & Supplies

This stock can be held in an Investment ISA and an Investment Account
Sell

$2.51

Buy

$2.52

arrow-down$-0.09 (-3.46%)

OraSure Technologies Inc develops, manufactures, markets and sells oral fluid diagnostic products and specimen collection devices using its proprietary oral fluid technologies.
Prices updated at 09 May 2025, 21:05 EDT
| Prices minimum 15 mins delay
|
Prices in USD
Sector
Healthcare
Industry
Medical Instruments & Supplies
Chairman
-
CEO
Ms. Carrie Eglinton Manner
Most recent earnings
31 Dec 2024
Fiscal year end
31 Dec 2024
Employees
501
Head office
220 East First Street
Bethlehem
United States
18015
mobile
+1 610 882-1820
letter
investorinfo@orasure.com

Key personnel

Owner nameSalaryBonusAll other compensationTotal compensationRestricted stock award
Mr. Robert W. McMahon
Independent Director
0.08m--0.18m-
Ms. Mara Glickman Aspinall
Chairwoman of the Board
0.09m--0.22m-
Ms. Carrie Eglinton Manner
Director, President and Chief Executive Officer
0.72m--5.60m-
Mr. John Patrick Kenny
Independent Director
-----
Ms. Michele Anthony
Senior Vice President, Controller and Chief Accounting Officer
-----
Ms. Kathleen Gallagher Weber
Chief Product Officer
0.49m--1.40m-
Dr. David J. Shulkin, M.D.
Independent Director
0.07m--0.17m-
Mr. Lelio Marmora
Independent Director
0.07m--0.17m-
Dr. Nancy J. Gagliano, M.D.
Independent Director
0.09m--0.19m-
Mr. Kenneth J. McGrath
Chief Financial Officer
0.50m--1.68m-

Top 5 shareholders

Owner nameNo. of sharesShare as % of port.Last changePortfolio % changeDate of portfolio% Total assets
BlackRock Inc6,976,4360.00051-652905-8.55781630 Apr 20259.00
Vanguard Group Inc. ( Junked)4,381,276-4381276-30 Apr 20255.87
Private Management Group Inc4,417,2270.535514417227-30 Apr 20255.70
Vanguard Group Inc4,297,3350.00027-83941-1.91590330 Apr 20255.55
Camber Capital Management LLC4,250,0000.35487--30 Apr 20255.48

Director dealings

DateActionNamePriceValueNo. of sharesHolding (%)Additional info
08 Aug 2024-Mr. Kenneth J. McGrath4.5987,752307,013--
04 Jun 2024-Ms. Carrie Eglinton Manner4.651,867,5241,181,039--
14 May 2024-Mr. James A. Datin5.2628,24182,146--
14 May 2024-Mr. Robert W. McMahon--42,646--
14 May 2024-Ms. Mara Glickman Aspinall5.2634,84989,716--
14 May 2024-Ms. Mara Glickman Aspinall--114,407--
14 May 2024-Dr. David J. Shulkin, M.D.--60,317--
14 May 2024-Dr. David J. Shulkin, M.D.5.2626,13540,374--
14 May 2024-Mr. Lelio Marmora--60,720--
14 May 2024-Mr. Lelio Marmora5.2620,84940,777--
14 May 2024-Dr. Nancy J. Gagliano--78,774--
26 Mar 2024-Mr. James A. Datin6.2220,00288,381--
26 Mar 2024-Mr. James A. Datin6.225,41587,510--
01 Mar 2024-Ms. Carrie Eglinton Manner7.19213,2361,582,657--
01 Mar 2024-Ms. Carrie Eglinton Manner--1,612,304--
01 Mar 2024-Ms. Michele Anthony7.1919,477101,954--
01 Mar 2024-Ms. Michele Anthony--104,662--
01 Mar 2024-Ms. Kathleen Gallagher Weber--301,295--
01 Mar 2024-Ms. Kathleen Gallagher Weber7.1931,669296,892--
01 Mar 2024-Mr. Kenneth J. McGrath--331,747--
Please note that past performance is not a reliable indicator of future returns.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.